Dr. Ronak K. Lakhia, MD

Dr. Lakhia practices at UT of Texas Southwestern University Hospital - William P. Clements Jr. - HOPD (5939 Harry Hines Blve) in Dallas, Texas.

Dr. Lakhia's NPI, 1154583383, was assigned on June 29, 2008. Dr. Lakhia graduated from UT Southwestern Medical Center in 2008. Dr. Lakhia's Texas license number on file is N7825.

Dr. Lakhia's primary practice is UT of Texas Southwestern University Hospital - William P. Clements Jr. - HOPD (5939 Harry Hines Blve), at 5939 Harry Hines Blve, Dallas, TX 75235.

Dr. Lakhia's primary practice is UT of Texas Southwestern University Hospital - William P. Clements Jr. - HOPD (5939 Harry Hines Blve) in Dallas, Texas. Dr. Lakhia is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Lakhia to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Lakhia's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lakhia practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lakhia's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lakhia is board certified in nephrology by the American Board of Internal Medicine. Dr. Lakhia has a license on file in Texas.

Dmand AI lists fluid and electrolyte imbalances among the conditions Dr. Lakhia treats.

CMS data shows 27 Medicare services from Dr. Lakhia across 2 procedure codes in 2024, for 36 Medicare patients. Medicare paid $1,912 for them.

CMS counts 36 Medicare patients who saw Dr. Lakhia in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lakhia's median patient age at 51, with 52% women.

In 2017, Dr. Lakhia wrote 19 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $81 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Lakhia for performance year 2024, reported as part of a group. Dr. Lakhia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lakhia as offering telehealth.

Dmand AI links 24 papers to Dr. Lakhia, published from 2007 to 2025. 2015 was the busiest year, with 4. The most frequent topics are MicroRNAs, Polycystic Kidney, Autosomal Dominant and Disease Models, Animal. Dr. Lakhia has published most often in Nat Commun. Dr. Lakhia's most frequent co-authors are Malcolm Pol Macconmara, MB, BCH, Nilum Rajora, MD and Christopher Paul Chaney, MD.

Dmand AI links Dr. Lakhia to 2 clinical trials, 2 of them phase 1 studies. Conditions studied include Polycystic Kidney, Autosomal Dominant and Polycystic Kidney Diseases. Regulus Therapeutics Inc. sponsors the most, 2.

CMS Open Payments shows 3 general payments to Dr. Lakhia from 1 drug or device company in 2025. Consulting fees make up the largest share, 100% of the total. Vertex Pharmaceuticals Incorporated paid the most, $10,375.

Dr. Lakhia graduated from UT Southwestern Medical Center in 2008.

Dr. Lakhia is in network with 20 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.